Stoke Therapeutics

STOK · Biotechnology

Verified executive transcripts, quotes, and interview insights from Stoke Therapeutics leadership.

1
Executives Tracked

About Stoke Therapeutics

Clinical-stage company developing antisense medicines for haploinsufficient diseases such as Dravet syndrome. [BIOTECH-2026-10-04]

Access All Stoke Therapeutics Executive Data

Search transcripts, quotes, and verified statements from every Stoke Therapeutics executive via our platform or API.